vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and ThredUp Inc. (TDUP). Click either name above to swap in a different company.

ThredUp Inc. is the larger business by last-quarter revenue ($79.7M vs $47.7M, roughly 1.7× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -7.0%, a 2.2% gap on every dollar of revenue. On growth, ThredUp Inc. posted the faster year-over-year revenue change (18.5% vs -47.3%). Over the past eight quarters, ThredUp Inc.'s revenue compounded faster (9.3% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

ThredUp Inc. is an American company that operates an online resale platform specializing in the sale of second-hand clothing, footwear, and accessories. Founded in 2009 and headquartered in Oakland, California, it has established itself as one of the leading resale fashion marketplaces.

IRWD vs TDUP — Head-to-Head

Bigger by revenue
TDUP
TDUP
1.7× larger
TDUP
$79.7M
$47.7M
IRWD
Growing faster (revenue YoY)
TDUP
TDUP
+65.8% gap
TDUP
18.5%
-47.3%
IRWD
Higher net margin
IRWD
IRWD
2.2% more per $
IRWD
-4.8%
-7.0%
TDUP
Faster 2-yr revenue CAGR
TDUP
TDUP
Annualised
TDUP
9.3%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IRWD
IRWD
TDUP
TDUP
Revenue
$47.7M
$79.7M
Net Profit
$-2.3M
$-5.6M
Gross Margin
79.6%
Operating Margin
14.3%
12.0%
Net Margin
-4.8%
-7.0%
Revenue YoY
-47.3%
18.5%
Net Profit YoY
-200.9%
72.4%
EPS (diluted)
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
TDUP
TDUP
Q1 26
$79.7M
Q4 25
$47.7M
$79.7M
Q3 25
$122.1M
$82.2M
Q2 25
$85.2M
$77.7M
Q1 25
$41.1M
$71.3M
Q4 24
$90.5M
$67.3M
Q3 24
$91.6M
$61.5M
Q2 24
$94.4M
$66.7M
Net Profit
IRWD
IRWD
TDUP
TDUP
Q1 26
$-5.6M
Q4 25
$-2.3M
$-5.6M
Q3 25
$40.1M
$-4.2M
Q2 25
$23.6M
$-5.2M
Q1 25
$-37.4M
$-5.2M
Q4 24
$2.3M
$-21.7M
Q3 24
$3.6M
$-24.8M
Q2 24
$-860.0K
$-14.0M
Gross Margin
IRWD
IRWD
TDUP
TDUP
Q1 26
79.6%
Q4 25
79.6%
Q3 25
79.4%
Q2 25
79.5%
Q1 25
79.1%
Q4 24
80.4%
Q3 24
79.3%
Q2 24
78.8%
Operating Margin
IRWD
IRWD
TDUP
TDUP
Q1 26
12.0%
Q4 25
14.3%
-8.4%
Q3 25
61.8%
-5.3%
Q2 25
53.2%
-6.8%
Q1 25
-70.7%
-7.6%
Q4 24
34.8%
-12.1%
Q3 24
28.0%
-17.0%
Q2 24
26.5%
-14.4%
Net Margin
IRWD
IRWD
TDUP
TDUP
Q1 26
-7.0%
Q4 25
-4.8%
-7.0%
Q3 25
32.8%
-5.2%
Q2 25
27.7%
-6.7%
Q1 25
-90.9%
-7.3%
Q4 24
2.5%
-32.3%
Q3 24
4.0%
-40.3%
Q2 24
-0.9%
-20.9%
EPS (diluted)
IRWD
IRWD
TDUP
TDUP
Q1 26
Q4 25
$0.01
$-0.06
Q3 25
$0.23
$-0.03
Q2 25
$0.14
$-0.04
Q1 25
$-0.23
$-0.04
Q4 24
$0.03
$-0.19
Q3 24
$0.02
$-0.22
Q2 24
$-0.01
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
TDUP
TDUP
Cash + ST InvestmentsLiquidity on hand
$215.5M
$38.6M
Total DebtLower is stronger
$18.2M
Stockholders' EquityBook value
$-261.8M
$59.2M
Total Assets
$396.9M
$167.2M
Debt / EquityLower = less leverage
0.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
TDUP
TDUP
Q1 26
$38.6M
Q4 25
$215.5M
$38.6M
Q3 25
$140.4M
$46.2M
Q2 25
$92.9M
$41.0M
Q1 25
$108.5M
$41.1M
Q4 24
$88.6M
$31.9M
Q3 24
$88.2M
$43.7M
Q2 24
$105.5M
$44.8M
Total Debt
IRWD
IRWD
TDUP
TDUP
Q1 26
$18.2M
Q4 25
Q3 25
$199.5M
Q2 25
$199.3M
Q1 25
$199.2M
Q4 24
$199.0M
Q3 24
$198.8M
Q2 24
$198.6M
Stockholders' Equity
IRWD
IRWD
TDUP
TDUP
Q1 26
$59.2M
Q4 25
$-261.8M
$59.2M
Q3 25
$-264.2M
$59.1M
Q2 25
$-308.2M
$60.2M
Q1 25
$-334.1M
$56.1M
Q4 24
$-301.3M
$56.3M
Q3 24
$-311.3M
$69.3M
Q2 24
$-321.7M
$86.5M
Total Assets
IRWD
IRWD
TDUP
TDUP
Q1 26
$167.2M
Q4 25
$396.9M
$167.2M
Q3 25
$396.1M
$172.5M
Q2 25
$342.9M
$173.6M
Q1 25
$327.2M
$172.5M
Q4 24
$350.9M
$171.2M
Q3 24
$389.5M
$214.9M
Q2 24
$395.6M
$231.2M
Debt / Equity
IRWD
IRWD
TDUP
TDUP
Q1 26
0.31×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
TDUP
TDUP
Operating Cash FlowLast quarter
$74.6M
Free Cash FlowOCF − Capex
$74.6M
FCF MarginFCF / Revenue
156.3%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$127.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
TDUP
TDUP
Q1 26
Q4 25
$74.6M
$-1.5M
Q3 25
$47.6M
$6.0M
Q2 25
$-15.1M
$344.0K
Q1 25
$20.0M
$5.7M
Q4 24
$15.2M
$663.0K
Q3 24
$9.9M
$3.3M
Q2 24
$33.5M
$-5.0M
Free Cash Flow
IRWD
IRWD
TDUP
TDUP
Q1 26
Q4 25
$74.6M
$-3.2M
Q3 25
$47.6M
$2.4M
Q2 25
$-15.1M
$-2.9M
Q1 25
$19.9M
$3.9M
Q4 24
$-1.8M
Q3 24
$9.9M
$1.2M
Q2 24
$33.4M
$-5.8M
FCF Margin
IRWD
IRWD
TDUP
TDUP
Q1 26
Q4 25
156.3%
-4.0%
Q3 25
39.0%
2.9%
Q2 25
-17.7%
-3.8%
Q1 25
48.4%
5.5%
Q4 24
-2.7%
Q3 24
10.8%
2.0%
Q2 24
35.4%
-8.7%
Capex Intensity
IRWD
IRWD
TDUP
TDUP
Q1 26
Q4 25
0.0%
2.2%
Q3 25
0.0%
4.4%
Q2 25
0.0%
4.2%
Q1 25
0.1%
2.5%
Q4 24
0.0%
3.7%
Q3 24
0.0%
3.5%
Q2 24
0.1%
1.3%
Cash Conversion
IRWD
IRWD
TDUP
TDUP
Q1 26
Q4 25
Q3 25
1.19×
Q2 25
-0.64×
Q1 25
Q4 24
6.74×
Q3 24
2.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons